Chlorprothixen Holsten

Chlorprothixen Holsten may be available in the countries listed below.

Ingredient matches for Chlorprothixen Holsten

Chlorprothixene

Chlorprothixene hydrochloride (a derivative of Chlorprothixene) is reported as an ingredient of Chlorprothixen Holsten in the following countries:

• Germany

International Drug Name Search

Pristine

Pristine may be available in the countries listed below.

Ingredient matches for Pristine

Amlodipine

Amlodipine is reported as an ingredient of Pristine in the following countries:

• Bangladesh

Ketoconazole

Ketoconazole is reported as an ingredient of Pristine in the following countries:

• Hong Kong


• Myanmar


• Singapore

International Drug Name Search

Nistatin Pliva

Nistatin Pliva may be available in the countries listed below.

Ingredient matches for Nistatin Pliva

Nystatin

Nystatin is reported as an ingredient of Nistatin Pliva in the following countries:

• Croatia (Hrvatska)

International Drug Name Search

Novo-Ranidine

Novo-Ranidine may be available in the countries listed below.

Ingredient matches for Novo-Ranidine

Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Novo-Ranidine in the following countries:

• Poland

International Drug Name Search

Esophageal Spasm Medications

Definition of Esophageal Spasm: Esophageal spasms involve irregular contractions of the muscles in the esophagus, which is the tube that carries food from the mouth to the stomach. These spasms do not propel food effectively to the stomach.

Drugs associated with Esophageal Spasm

The following drugs and medications are in some way related to, or used in the treatment of Esophageal Spasm. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Esophageal Spasm

Medical Encyclopedia:

• Esophageal spasm

Drug List:

Dilatrate-Sr

Isochron

Isoditrate

Isordil

Isordil-Titradose

Syncro Part

Syncro Part may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Syncro Part

Flugestone

Flugestone 17α-acetate (a derivative of Flugestone) is reported as an ingredient of Syncro Part in the following countries:

• France

International Drug Name Search

Amlodipine Besilate

Amlodipine Besilate may be available in the countries listed below.

Ingredient matches for Amlodipine Besilate

Amlodipine

Amlodipine Besilate (BANM, JAN) is known as Amlodipine in the US.

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)
JAN	Japanese Accepted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Retavase Half-Kit

Pronunciation: reh-TEH-plase
Generic Name: Reteplase
Brand Name: Retavase and Retavase Half-Kit

Retavase Half-Kit is used for:

Improving heart function and reducing long-term effects of a heart attack. It may also be used for other conditions as determined by your doctor.

Retavase Half-Kit is a tissue plasminogen activator. It works by activating a substance that helps to break up blood clots. Blood clots can prevent oxygen and nutrients from getting to the heart, which causes tissue death and long-term damage to the heart.

Do NOT use Retavase Half-Kit if:

• you are allergic to any ingredient in Retavase Half-Kit


• you have an aneurysm, heart or blood vessel defects, bleeding disorders, severe uncontrolled high blood pressure, a history of stroke, or internal bleeding; you have had brain or spinal surgery; or you have suffered recent trauma

Contact your doctor or health care provider right away if any of these apply to you.

Before using Retavase Half-Kit:

Some medical conditions may interact with Retavase Half-Kit. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a disease or infection in the heart, brain, or blood vessels; severe liver or kidney disease; blood in the urine or stool; a stomach ulcer that is bleeding; high blood pressure; or bleeding in your eye because of diabetes or other conditions; you are taking blood thinners; or you have had recent major surgery

Some MEDICINES MAY INTERACT with Retavase Half-Kit. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Blood thinners (eg, warfarin, heparin, enoxaparin) because the risk of bleeding will be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Retavase Half-Kit may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Retavase Half-Kit:

Use Retavase Half-Kit as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Retavase Half-Kit is usually administered as an injection at your doctor's office, hospital, or clinic.


• If you miss a dose of Retavase Half-Kit, contact your doctor immediately.

Ask your health care provider any questions you may have about how to use Retavase Half-Kit.

Important safety information:

• Before you have any medical or dental treatments, emergency care, or surgery, tell the doctor or dentist that you are using Retavase Half-Kit.


• Retavase Half-Kit may reduce the number of clot-forming cells (platelets) in your blood. To prevent bleeding, avoid situations in which bruising or injury may occur. Report any unusual bleeding, bruising, blood in stools, or dark, tarry stools to your doctor.


• Retavase Half-Kit is not recommended for use in CHILDREN. Safety and effectiveness have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Retavase Half-Kit, discuss with your doctor the benefits and risks of using Retavase Half-Kit during pregnancy. It is unknown if Retavase Half-Kit is excreted in breast milk. If you are or will be breast-feeding while you are using Retavase Half-Kit, check with your doctor or pharmacist to discuss the risks to your baby.

Possible side effects of Retavase Half-Kit:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Pain, redness, or swelling at the injection site.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); black, tarry stools; bleeding at the injection site; chest pain; severe bleeding; sudden, severe headache; trouble breathing; vomiting blood or material that looks like coffee grounds.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Retavase Half-Kit side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Retavase Half-Kit:

Retavase Half-Kit is usually handled and stored by a health care provider. If you are using Retavase Half-Kit at home, store Retavase Half-Kit as directed by your pharmacist or health care provider.

General information:

• If you have any questions about Retavase Half-Kit, please talk with your doctor, pharmacist, or other health care provider.


• Retavase Half-Kit is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Retavase Half-Kit. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Retavase Half-Kit resources

• Retavase Half-Kit Side Effects (in more detail)
• Retavase Half-Kit Use in Pregnancy & Breastfeeding
• Retavase Half-Kit Drug Interactions
• Retavase Half-Kit Support Group
• 0 Reviews for Retavase Half-Kit - Add your own review/rating

Compare Retavase Half-Kit with other medications

• Heart Attack

Diarrhea, Acute Medications

Drugs associated with Diarrhea, Acute

The following drugs and medications are in some way related to, or used in the treatment of Diarrhea, Acute. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Topics under Diarrhea, Acute

• Infectious Diarrhea (31 drugs in 4 topics)

Learn more about Diarrhea, Acute

Medical Encyclopedia:

• Diarrhea
• Bacterial gastroenteritis
• Drug-induced diarrhea
• Traveler's diarrhea diet
• Viral gastroenteritis

Drug List:

Leader-Anti-Diarrheal

Diamode

Imodium

Imodium-A-D

Imodium-Multi-Symptom-Relief

Imotil

Kao-Paverin

Kaopectate-1-D

Motofen

Up-And-Up-Anti-Diarrheal-Solution

Barutoneru

Barutoneru may be available in the countries listed below.

Ingredient matches for Barutoneru

Fleroxacin

Fleroxacin is reported as an ingredient of Barutoneru in the following countries:

• Japan

International Drug Name Search

B12-Rotexmedica

B12-Rotexmedica may be available in the countries listed below.

Ingredient matches for B12-Rotexmedica

Cyanocobalamin

Cyanocobalamin is reported as an ingredient of B12-Rotexmedica in the following countries:

• Germany

International Drug Name Search

Sulfadiazin-Heyl

Sulfadiazin-Heyl may be available in the countries listed below.

Ingredient matches for Sulfadiazin-Heyl

Sulfadiazine

Sulfadiazine is reported as an ingredient of Sulfadiazin-Heyl in the following countries:

• Germany

International Drug Name Search

Sildenafilo Genfar

Sildenafilo Genfar may be available in the countries listed below.

Ingredient matches for Sildenafilo Genfar

Sildenafil

Sildenafil citrate (a derivative of Sildenafil) is reported as an ingredient of Sildenafilo Genfar in the following countries:

• Peru

International Drug Name Search

Quinapril beta comp

Quinapril beta comp may be available in the countries listed below.

Ingredient matches for Quinapril beta comp

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Quinapril beta comp in the following countries:

• Germany

Quinapril

Quinapril is reported as an ingredient of Quinapril beta comp in the following countries:

• Germany

International Drug Name Search

Treximet

In the US, Treximet (naproxen/sumatriptan systemic) is a member of the drug class antimigraine agents and is used to treat Migraine.

US matches:

• Treximet

Ingredient matches for Treximet

Naproxen

Naproxen sodium salt (a derivative of Naproxen) is reported as an ingredient of Treximet in the following countries:

• United States

Sumatriptan

Sumatriptan is reported as an ingredient of Treximet in the following countries:

• United States

International Drug Name Search

Pharmaseal Scrub Care

Ingredient matches for Pharmaseal Scrub Care

Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Pharmaseal Scrub Care in the following countries:

• United States

International Drug Name Search

Zoladex Trimestral

Zoladex Trimestral may be available in the countries listed below.

Ingredient matches for Zoladex Trimestral

Goserelin

Goserelin acetate (a derivative of Goserelin) is reported as an ingredient of Zoladex Trimestral in the following countries:

• Spain

International Drug Name Search

Tetracycline-H

Tetracycline-H may be available in the countries listed below.

Ingredient matches for Tetracycline-H

Tetracycline

Tetracycline hydrochloride (a derivative of Tetracycline) is reported as an ingredient of Tetracycline-H in the following countries:

• Bangladesh

International Drug Name Search

Zelefion

Zelefion may be available in the countries listed below.

Ingredient matches for Zelefion

Terbinafine

Terbinafine is reported as an ingredient of Zelefion in the following countries:

• Poland

Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of Zelefion in the following countries:

• Poland

International Drug Name Search

Vistagan

Vistagan may be available in the countries listed below.

Ingredient matches for Vistagan

Levobunolol

Levobunolol hydrochloride (a derivative of Levobunolol) is reported as an ingredient of Vistagan in the following countries:

• Austria


• Colombia


• Croatia (Hrvatska)


• Czech Republic


• Germany


• Greece


• Hungary


• Italy


• Slovakia


• Venezuela

Timolol

Timolol maleate (a derivative of Timolol) is reported as an ingredient of Vistagan in the following countries:

• Peru

International Drug Name Search

Probucolo

Probucolo may be available in the countries listed below.

Ingredient matches for Probucolo

Probucol

Probucolo (DCIT) is known as Probucol in the US.

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Biorganic Vitamin-C Gisand

Biorganic Vitamin-C Gisand may be available in the countries listed below.

Ingredient matches for Biorganic Vitamin-C Gisand

Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Biorganic Vitamin-C Gisand in the following countries:

• Switzerland

International Drug Name Search

Mycopol

Mycopol may be available in the countries listed below.

Ingredient matches for Mycopol

Undecylenic Acid

Undecylenic Acid is reported as an ingredient of Mycopol in the following countries:

• Austria

International Drug Name Search

Stephadilat-S

Stephadilat-S may be available in the countries listed below.

Ingredient matches for Stephadilat-S

Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Stephadilat-S in the following countries:

• Greece

International Drug Name Search

Valtropin

Ingredient matches for Valtropin

Somatropine

Somatropine is reported as an ingredient of Valtropin in the following countries:

• Germany


• Luxembourg


• United States

International Drug Name Search

Zetonna

Zetonna is a brand name of ciclesonide nasal, approved by the FDA in the following formulation(s):

ZETONNA (ciclesonide - aerosol, metered; nasal)

• 
  Manufacturer: NYCOMED GMBH
  
  Approval date: January 20, 2012
  
  Strength(s): 0.037MG/INH ^[RLD]

Has a generic version of Zetonna been approved?

No. There is currently no therapeutically equivalent version of Zetonna available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zetonna. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Pregna-1,4-diene3,20-dione-16-17-acetal-21 esters, process for their preparation, composition, and methods for the treatment of inflammatory conditions
  Patent 5,482,934
  Issued: January 9, 1996
  Inventor(s): Calatayud; Jose & Conde; Jose R. & Luna; Manuel
  Assignee(s): Especialidades Latinas Medicamentos Universales, S.A. (Elmu, S.A.)
  The present invention relates to compounds of the formula: ##STR1## in which X.sub.1 and X.sub.2 correspond to H or F without distinction; R.sub.1 represents the following radicals: ##STR2## and R.sub.2 represents the radicals ##STR3## in the form of an R epimer, an S epimer, or a stereoisomeric mixture of the R and S epimers in terms of the orientation of the substituents on the carbon atom at position 22, novel intermediates and a method of their preparation by hydrolysis-ketalization, and use of such compounds as drugs and/or therapeutic agents.
  
  Patent expiration dates:
  
  
  • October 24, 2017
    
    ✓ 
    Patent use: METHOD OF TREATING INFLAMMATORY CONDITIONS
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  



• 
  Medicinal aerosol formulations
  Patent 5,605,674
  Issued: February 25, 1997
  Inventor(s): Purewal; Tarlochan S. & Greenleaf; David J.
  Assignee(s): Riker Laboratories, Inc.
  A self-propelling aerosol formulation which may be free from CFC's which comprises a medicament, 1,1,1,2-tetrafluoroethane, a surface active agent and at least one compound having a higher polarity than 1,1,1,2-tetrafluoroethane.
  
  Patent expiration dates:
  
  
  • February 25, 2014
    
    ✓ 
    Drug product
  
  



• 
  Medicinal aerosol formulations
  Patent 5,683,677
  Issued: November 4, 1997
  Inventor(s): Purewal; Tarlochan S. & Greenleaf; David J.
  Assignee(s): Riker Laboratories, Inc.
  A self-propelling aerosol formulation which may be free from CFC's which comprises a medicament, 1,1,1,2-tetrafluoroethane, a surface active agent and at least one compound having a higher polarity than 1,1,1,2-tetrafluoroethane.
  
  Patent expiration dates:
  
  
  • November 4, 2014
    
    ✓ 
    Drug product
  
  



• 
  Seal configuration for aerosol canister
  Patent 5,775,321
  Issued: July 7, 1998
  Inventor(s): Alband; Todd D.
  Assignee(s): Minnesota Mining and Manufacturing Company
  A dual seal configuration for an aerosol canister containing a medicinal aerosol formulation. The canister includes a vial body and valve ferrule sealed by first and second sealing members to form a chamber that contains the medicinal aerosol formulation. The dual seal configuration reduces leakage of contents, and is particularly helpful where the formulation includes hydrofluorocarbon propellant and an ethanol cosolvent. The first seal can be selected to be a barrier to the formulation components, while the second seal can be relatively more labile to such components.
  
  Patent expiration dates:
  
  
  • July 7, 2015
    
    ✓ 
    Drug product
  
  



• 
  Device for delivering an aerosol
  Patent 6,006,745
  Issued: December 28, 1999
  Inventor(s): Marecki; Paul E.
  Assignee(s): Minnesota Mining and Manufacturing Company
  A device for delivering an aerosol comprises a casing member, a valve stem, and a sealing member, wherein the sealing member comprises a thermoplastic elastomer comprising of a copolymer of about 80-95 mole % ethylene and about 5-20 mole % of at least one comonomer wherein the comonomer(s) are 1-butene, 1-hexene, or 1-octene. The device is used with pharmaceutical formulations containing 1,1,1,2-tetrafluoroethane and/or 1,1,1,2,3,3,3-heptafluoropropane as the propellant.
  
  Patent expiration dates:
  
  
  • December 28, 2016
    
    ✓ 
    Drug product
  
  



• 
  Seal configuration for aerosol canister
  Patent 6,036,942
  Issued: March 14, 2000
  Inventor(s): Alband; Todd D.
  Assignee(s): 3M Innovative Properties Company
  An aerosol canister for containing a medicinal aerosol formulation. The canister involves a vial body and a valve ferrule sealed by first and second sealing members to form a chamber that contains the medicinal aerosol formulation.
  
  Patent expiration dates:
  
  
  • April 30, 2013
    
    ✓ 
    Drug product
  
  



• 
  Medicinal aerosol products containing formulations of ciclesonide and related steroids
  Patent 6,120,752
  Issued: September 19, 2000
  Inventor(s): Oliver; Martin J. & Fatania; Kanu M. & Scott; John S. & Muller; Helgert
  Assignee(s): 3M Innovative Properties Company
  Byk Gulden Lomberg Chemische Fabrik GmbH
  A pharmaceutical aerosol formulation suitable for oral and/or nasal inhalation including an anti-inflammatory steroid of the formula ##STR1## in which: R.sub.1 is 1-butyl, 2-butyl, cyclohexyl or phenyl and R.sub.2 is acetyl or isobutanoyl, in particular ciclesonide. The formulations also include hydrofluorocarbon propellants such as HFC 134a and/or 227, and cosolvent such as ethanol in an amount sufficient to solubilize the ciclesonide or related steroid (and various optional ingredients, such as surfactant). The formulations exhibit very desirable physical and chemical stability, as well as excellent delivery characteristics.
  
  Patent expiration dates:
  
  
  • May 13, 2018
    
    ✓ 
    Drug product
  
  



• 
  Medicinal aerosol formulation of ciclesonide and related compounds
  Patent 6,264,923
  Issued: July 24, 2001
  Inventor(s): Oliver; Martin J. & Fatania; Kanu M. & Scott; John S. & Muller; Helgert
  Assignee(s): 3M Innovative Properties Company
  A pharmaceutical aerosol formulation suitable for oral and/or nasal inhalation including an anti-inflammatory steroid of the formula ##STR1## in which: R.sub.1 is 1-butyl, 2-butyl, cyclohexyl or phenyl and R.sub.2 is acetyl or isobutanoyl, in particular ciclesonide. The formulations also include hydrofluorocarbon propellants such as HFC 134a and/or 227, and cosolvent such as ethanol in an amount sufficient to solubilize the ciclesonide or related steroid (and various optional ingredients, such as surfactant). The formulations exhibit very desirable physical and chemical stability, as well as excellent delivery characteristics.
  
  Patent expiration dates:
  
  
  • May 13, 2018
    
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • January 20, 2015 - NEW PRODUCT
  
  

See also...

• Zetonna Consumer Information (Drugs.com)
• Ciclesonide Spray Consumer Information (Wolters Kluwer)
• Ciclesonide nasal Consumer Information (Cerner Multum)
• Ciclesonide Nasal Advanced Consumer Information (Micromedex)
• Ciclesonide AHFS DI Monographs (ASHP)

Rupan

Rupan may be available in the countries listed below.

Ingredient matches for Rupan

Ibuprofen

Ibuprofen is reported as an ingredient of Rupan in the following countries:

• Romania


• Serbia

International Drug Name Search

Vitamin A Streuli

Vitamin A Streuli may be available in the countries listed below.

Ingredient matches for Vitamin A Streuli

Retinol

Retinol palmitate (a derivative of Retinol) is reported as an ingredient of Vitamin A Streuli in the following countries:

• Switzerland

International Drug Name Search

Meclid

Meclid may be available in the countries listed below.

Ingredient matches for Meclid

Metoclopramide

Metoclopramide hydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Meclid in the following countries:

• Bangladesh

International Drug Name Search

Fluconazolo FG

Fluconazolo FG may be available in the countries listed below.

Ingredient matches for Fluconazolo FG

Fluconazole

Fluconazole is reported as an ingredient of Fluconazolo FG in the following countries:

• Italy

International Drug Name Search

Abacten

Abacten may be available in the countries listed below.

Ingredient matches for Abacten

Azithromycin

Azithromycin is reported as an ingredient of Abacten in the following countries:

• Chile


• Peru

International Drug Name Search

Estraderm Matrix

Estraderm Matrix may be available in the countries listed below.

Ingredient matches for Estraderm Matrix

Estradiol

Estradiol is reported as an ingredient of Estraderm Matrix in the following countries:

• Spain

International Drug Name Search

Terbocyl

Terbocyl may be available in the countries listed below.

Ingredient matches for Terbocyl

Benzylpenicillin

Benzylpenicillin benzathine (a derivative of Benzylpenicillin) is reported as an ingredient of Terbocyl in the following countries:

• Peru

International Drug Name Search

Modivid

Modivid may be available in the countries listed below.

Ingredient matches for Modivid

Cefodizime

Cefodizime disodium salt (a derivative of Cefodizime) is reported as an ingredient of Modivid in the following countries:

• Italy


• Portugal


• Turkey

International Drug Name Search

AP-Loratadine

AP-Loratadine may be available in the countries listed below.

Ingredient matches for AP-Loratadine

Loratadine

Loratadine is reported as an ingredient of AP-Loratadine in the following countries:

• South Africa

International Drug Name Search

Biaxin

See also: Generic Biaxin XL

Biaxin is a brand name of clarithromycin, approved by the FDA in the following formulation(s):

BIAXIN (clarithromycin - for suspension; oral)

• 
  Manufacturer: ABBOTT
  
  Approval date: December 23, 1993
  
  Strength(s): 125MG/5ML ^[AB], 250MG/5ML ^[RLD][AB]

BIAXIN (clarithromycin - tablet; oral)

• 
  Manufacturer: ABBOTT
  
  Approval date: October 31, 1991
  
  Strength(s): 250MG ^[RLD][AB], 500MG ^[RLD][AB]

Has a generic version of Biaxin been approved?

Yes. The following products are equivalent to Biaxin:

clarithromycin for suspension; oral

• 
  Manufacturer: RANBAXY
  
  Approval date: August 30, 2007
  
  Strength(s): 125MG/5ML ^[AB], 250MG/5ML ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: September 4, 2007
  
  Strength(s): 125MG/5ML ^[AB], 250MG/5ML ^[AB]

clarithromycin tablet; oral

• 
  Manufacturer: APOTEX CORP
  
  Approval date: August 20, 2007
  
  Strength(s): 250MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: March 11, 2005
  
  Strength(s): 250MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: RANBAXY
  
  Approval date: September 24, 2004
  
  Strength(s): 250MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: ROXANE
  
  Approval date: May 25, 2004
  
  Strength(s): 250MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: August 25, 2005
  
  Strength(s): 500MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: October 18, 2005
  
  Strength(s): 250MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: May 31, 2005
  
  Strength(s): 250MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: WOCKHARDT
  
  Approval date: May 31, 2006
  
  Strength(s): 250MG ^[AB], 500MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Biaxin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Biaxin.

See also...

• Biaxin Consumer Information (Drugs.com)
• Biaxin Consumer Information (Wolters Kluwer)
• Biaxin Suspension Consumer Information (Wolters Kluwer)
• Biaxin Consumer Information (Cerner Multum)
• Biaxin Advanced Consumer Information (Micromedex)
• Biaxin Filmtab Advanced Consumer Information (Micromedex)
• Clarithromycin Consumer Information (Drugs.com)
• Clarithromycin Consumer Information (Wolters Kluwer)
• Clarithromycin Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Clarithromycin Suspension Consumer Information (Wolters Kluwer)
• Clarithromycin Consumer Information (Cerner Multum)
• Clarithromycin Advanced Consumer Information (Micromedex)
• Clarithromycin AHFS DI Monographs (ASHP)

Doxazin

Doxazin may be available in the countries listed below.

Ingredient matches for Doxazin

Doxazosin

Doxazosin is reported as an ingredient of Doxazin in the following countries:

• Croatia (Hrvatska)

International Drug Name Search

Folinezuur EuroCept

Folinezuur EuroCept may be available in the countries listed below.

Ingredient matches for Folinezuur EuroCept

Calcium Folinate

Calcium Folinate pentahydrate (a derivative of Calcium Folinate) is reported as an ingredient of Folinezuur EuroCept in the following countries:

• Netherlands

International Drug Name Search

Clarithromycin Ratiopharm

Clarithromycin-ratiopharm may be available in the countries listed below.

Ingredient matches for Clarithromycin-ratiopharm

Clarithromycin

Clarithromycin is reported as an ingredient of Clarithromycin-ratiopharm in the following countries:

• Austria


• Czech Republic


• Denmark


• Germany


• Hungary


• Luxembourg


• Slovakia

International Drug Name Search

Colluxid

Colluxid may be available in the countries listed below.

Ingredient matches for Colluxid

Chlorhexidine

Chlorhexidine is reported as an ingredient of Colluxid in the following countries:

• Tunisia

International Drug Name Search

Siclidon

Siclidon may be available in the countries listed below.

Ingredient matches for Siclidon

Doxycycline

Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Siclidon in the following countries:

• Indonesia

International Drug Name Search

Risperidona Sumol

Risperidona Sumol may be available in the countries listed below.

Ingredient matches for Risperidona Sumol

Risperidone

Risperidone is reported as an ingredient of Risperidona Sumol in the following countries:

• Spain

International Drug Name Search

Selex

Selex may be available in the countries listed below.

Ingredient matches for Selex

Cefalexin

Cefalexin is reported as an ingredient of Selex in the following countries:

• Bangladesh

International Drug Name Search

Broxol

Broxol may be available in the countries listed below.

Ingredient matches for Broxol

Ambroxol

Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Broxol in the following countries:

• Italy


• Mexico

International Drug Name Search

Pérical

Pérical may be available in the countries listed below.

Ingredient matches for Pérical

Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Pérical in the following countries:

• France

International Drug Name Search

Vedrop

Vedrop may be available in the countries listed below.

UK matches:

• Vedrop (SPC)

Ingredient matches for Vedrop

Tocofersolan

Tocofersolan is reported as an ingredient of Vedrop in the following countries:

• Germany


• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Flucozal

Flucozal may be available in the countries listed below.

Ingredient matches for Flucozal

Fluconazole

Fluconazole is reported as an ingredient of Flucozal in the following countries:

• Bulgaria


• Malta

International Drug Name Search

Aminophenazone

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N02BB03

CAS registry number (Chemical Abstracts Service)

0000058-15-1

Chemical Formula

C13-H17-N3-O

Molecular Weight

231

Therapeutic Categories

Analgesic, antipyretic and anti-inflammatory agent

Non-steroidal anti-inflammatory drug, NSAID

Chemical Name

3H-Pyrazol-3-one, 4-(dimethylamino)-1,2-dihydro-1,5-dimethyl-2-phenyl-

Foreign Names

• Aminophenazonum (Latin)
• Aminophenazon (German)
• Aminophénazone (French)
• Aminofenazona (Spanish)

Generic Names

• Aminofenazone (OS: DCIT)
• Aminophénazone (OS: DCF)
• Amidofebrin (IS)
• Amidophenazon (IS)
• Amidopyrin (IS)
• Aminopyrine (IS)
• Diamin (IS)
• Dimethylaminaphenazon (IS)
• Dimethylaminoantipyrin (IS)
• Dipyrin (IS)
• Pyramidon (IS)
• Aminofenazone (PH: F.U. IX)
• Aminophenazonum (PH: Ph. Helv. VI, Editio, Ph. Int. 2)
• Amminofenazone (PH: F.U. VIII)

Brand Name

• Amidophen
  Sopharma, Bulgaria

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Cefradril

Cefradril may be available in the countries listed below.

Ingredient matches for Cefradril

Cefadroxil

Cefadroxil monohydrate (a derivative of Cefadroxil) is reported as an ingredient of Cefradril in the following countries:

• Oman

International Drug Name Search

DDAVP

Pronunciation: DES-moe-PRES-in
Generic Name: Desmopressin
Brand Name: DDAVP

DDAVP is used for:

Treating nighttime bedwetting. It is also used to manage temporarily increased thirst and urination caused by head injury or certain types of brain surgery, or to manage certain types of diabetes (cranial diabetes insipidus). It may also be used for other conditions as determined by your doctor.

DDAVP is an antidiuretic hormone. It works by causing the kidneys to produce less urine.

Do NOT use DDAVP if:

• you are allergic to any ingredient in DDAVP


• you have moderate to severe kidney problems


• you have or have a history of low blood sodium levels (salt depletion)

Contact your doctor or health care provider right away if any of these apply to you.

Before using DDAVP:

Some medical conditions may interact with DDAVP. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have severe drowsiness


• if you have a history of kidney problems, heart problems (eg, heart blood vessel problems), or high blood pressure


• if you have cystic fibrosis, dehydration, fever, severe infection, vomiting or diarrhea, swelling or fluid retention, or abnormal blood electrolyte levels


• if you are exposed to very hot weather, are physically active, or drink a lot of water


• if you have recently had surgery in the head area

Some MEDICINES MAY INTERACT with DDAVP. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Carbamazepine, chlorpromazine, lamotrigine, narcotic analgesics (eg, codeine), nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, ibuprofen), oxybutynin, selective serotonin reuptake inhibitors (SSRIs) (eg, fluoxetine), or tricyclic antidepressants (eg, imipramine) because the risk of fluid overload with low blood sodium levels may be increased

Ask your health care provider if DDAVP may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use DDAVP:

Use DDAVP as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take DDAVP by mouth with or without food.


• If you miss a dose of DDAVP, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use DDAVP.

Important safety information:

• DDAVP may cause dizziness. These effects may be worse if you take it with alcohol or certain medicines. Use DDAVP with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Follow the fluid intake instructions given to you by your health care provider very carefully. Serious side effects may occur if you drink too much liquid while taking DDAVP.


• Check with your doctor if you experience infection, fever, vomiting, or diarrhea. Tell your doctor if you will be exposed to very hot weather, will be physically active, or will be increasing your water intake for any reason. The risk of low blood sodium levels may be increased.


• Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.


• Tell your doctor or dentist that you take DDAVP before you receive any medical or dental care, emergency care, or surgery.


• Lab tests, including urine volume or blood electrolyte levels, may be performed while you use DDAVP. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Use DDAVP with caution in the ELDERLY and in CHILDREN; they may be more sensitive to its effects, especially water overload. Signs of water overload may include severe or persistent nausea or headache, vomiting, or unusual weight gain.


• DDAVP should be used with extreme caution in CHILDREN younger than 6 years old if used for nighttime bedwetting; effectiveness for bedwetting in these children has not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using DDAVP while you are pregnant. It is not known if DDAVP is found in breast milk. If you are or will be breast-feeding while you are using DDAVP, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of DDAVP:

All medicines may cause side effects, but many people have no, or minor, side effects. No COMMON side effects have been reported with DDAVP. Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); confusion; fainting; loss of appetite; mental or mood changes (eg, agitation, irritability); muscle weakness, spasms, or cramps; nausea; personality changes; seizures; swelling; unusual headache or restlessness; unusual tiredness or sluggishness; unusual weight gain; vomiting.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: DDAVP side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include confusion; persistent headache; sudden weight gain; trouble urinating; unusual drowsiness.

Proper storage of DDAVP:

Store DDAVP at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Keep DDAVP out of the reach of children and away from pets.

General information:

• If you have any questions about DDAVP, please talk with your doctor, pharmacist, or other health care provider.


• DDAVP is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about DDAVP. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More DDAVP resources

• DDAVP Side Effects (in more detail)
• DDAVP Dosage
• DDAVP Use in Pregnancy & Breastfeeding
• Drug Images
• DDAVP Drug Interactions
• DDAVP Support Group
• 6 Reviews for DDAVP - Add your own review/rating

• DDAVP Concise Consumer Information (Cerner Multum)


• DDAVP Prescribing Information (FDA)


• DDAVP Advanced Consumer (Micromedex) - Includes Dosage Information


• Desmopressin Prescribing Information (FDA)


• DDAVP Rhinal Tube nasal Concise Consumer Information (Cerner Multum)


• Desmopressin Acetate Monograph (AHFS DI)


• Stimate Prescribing Information (FDA)

Compare DDAVP with other medications

• Diabetes Insipidus
• Hemophilia A
• Primary Nocturnal Enuresis
• von Willebrand's Disease

Esam

Esam may be available in the countries listed below.

Ingredient matches for Esam

Amlodipine

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Esam in the following countries:

• Myanmar

International Drug Name Search

Quiniduran

Quiniduran may be available in the countries listed below.

Ingredient matches for Quiniduran

Quinidine

Quinidine hydrogen sulfate (a derivative of Quinidine) is reported as an ingredient of Quiniduran in the following countries:

• Israel

International Drug Name Search

Promazine HCl

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Promazine HCl

Promazine

Promazine hydrochloride (a derivative of Promazine) is reported as an ingredient of Promazine HCl in the following countries:

• United States

International Drug Name Search

Bupivacain-Fentanyl Sintetica

Bupivacain-Fentanyl Sintetica may be available in the countries listed below.

Ingredient matches for Bupivacain-Fentanyl Sintetica

Bupivacaine

Bupivacaine hydrochloride (a derivative of Bupivacaine) is reported as an ingredient of Bupivacain-Fentanyl Sintetica in the following countries:

• Switzerland

Fentanyl

Fentanyl citrate (a derivative of Fentanyl) is reported as an ingredient of Bupivacain-Fentanyl Sintetica in the following countries:

• Switzerland

International Drug Name Search

Cobalti

Cobalti may be available in the countries listed below.

Ingredient matches for Cobalti

Ferric Ammonium Citrate

Ferric Ammonium Citrate is reported as an ingredient of Cobalti in the following countries:

• Portugal

International Drug Name Search

Curadona

Curadona may be available in the countries listed below.

Ingredient matches for Curadona

Povidone Iodine

Povidone-Iodine is reported as an ingredient of Curadona in the following countries:

• Spain

International Drug Name Search

Bilharzid

Bilharzid may be available in the countries listed below.

Ingredient matches for Bilharzid

Praziquantel

Praziquantel is reported as an ingredient of Bilharzid in the following countries:

• Ethiopia

International Drug Name Search

Devedryl

Devedryl may be available in the countries listed below.

Ingredient matches for Devedryl

Loratadine

Loratadine is reported as an ingredient of Devedryl in the following countries:

• Argentina

International Drug Name Search

Damicine

Damicine may be available in the countries listed below.

Ingredient matches for Damicine

Clindamycin

Clindamycin dihydrogen phosphate (a derivative of Clindamycin) is reported as an ingredient of Damicine in the following countries:

• Colombia

International Drug Name Search

Kelvin

Kelvin may be available in the countries listed below.

Ingredient matches for Kelvin

Paracetamol

Paracetamol is reported as an ingredient of Kelvin in the following countries:

• Ethiopia

International Drug Name Search

Palladia

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Palladia

Toceranib

Toceranib phosphate (a derivative of Toceranib) is reported as an ingredient of Palladia in the following countries:

• United States

International Drug Name Search

Fluticasone Furoate

Fluticasone Furoate may be available in the countries listed below.

Ingredient matches for Fluticasone Furoate

Fluticasone

Fluticasone Furoate (USAN) is known as Fluticasone in the US.

International Drug Name Search

Glossary

USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Vontrol

In the US, Vontrol (diphenidol systemic) is used to treat Meniere's Disease, Nausea/Vomiting, Nausea/Vomiting - Postoperative and Vertigo.

US matches:

• Vontrol

Ingredient matches for Vontrol

Difenidol

Difenidol hydrochloride (a derivative of Difenidol) is reported as an ingredient of Vontrol in the following countries:

• Chile


• El Salvador


• Mexico


• United States

International Drug Name Search

Sanoxit

Sanoxit may be available in the countries listed below.

Ingredient matches for Sanoxit

Benzoyl Peroxide

Benzoyl Peroxide is reported as an ingredient of Sanoxit in the following countries:

• Germany

International Drug Name Search

Deslorelin

In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0057773-65-6

Chemical Formula

C64-H83-N17-O12

Molecular Weight

1282

Therapeutic Category

Gonadotropin releasing hormone (GnRH) agonist

Chemical Name

5-oxo-L-Prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-tryptophyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide

Foreign Names

• Deslorelinum (Latin)
• Deslorelin (German)
• Desloreline (French)
• Deslorelina (Spanish)

Generic Names

• Deslorelin (OS: USAN, BAN)
• D-Trp LHRH-PEA (IS: Roberts)

Brand Names

• Ovuplant (veterinary use)
  Peptech Animal Health, Australia; Dechra Veterinary Products, France; Peptech, United States; Peptech Animal Health, New Zealand



• Suprelorin (veterinary use)
  Peptech Animal Health, Australia; Peptech Animal Health, New Zealand; Virbac, Switzerland; Virbac, Germany; Virbac, France

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Fluta-cell

Fluta-cell may be available in the countries listed below.

Ingredient matches for Fluta-cell

Flutamide

Flutamide is reported as an ingredient of Fluta-cell in the following countries:

• Germany

International Drug Name Search

Purubex

Purubex may be available in the countries listed below.

Ingredient matches for Purubex

Teprenone

Teprenone is reported as an ingredient of Purubex in the following countries:

• Indonesia

International Drug Name Search

Diatica

Diatica may be available in the countries listed below.

Ingredient matches for Diatica

Gliclazide

Gliclazide is reported as an ingredient of Diatica in the following countries:

• Russian Federation


• Sri Lanka

International Drug Name Search

Seduxen

Seduxen may be available in the countries listed below.

Ingredient matches for Seduxen

Diazepam

Diazepam is reported as an ingredient of Seduxen in the following countries:

• Estonia


• Hungary


• Latvia


• Lithuania


• Russian Federation

International Drug Name Search

Zephrazol

Zephrazol may be available in the countries listed below.

Ingredient matches for Zephrazol

Omeprazole

Omeprazole is reported as an ingredient of Zephrazol in the following countries:

• Indonesia

International Drug Name Search